Sign Up to like & get
recommendations!
1
Published in 2022 at "Science Translational Medicine"
DOI: 10.1126/scitranslmed.abm9043
Abstract: T cell–directed cancer immunotherapy often fails to generate lasting tumor control. Harnessing additional effectors of the immune response against tumors may strengthen the clinical benefit of immunotherapies. Here, we demonstrate that therapeutic targeting of the…
read more here.
Keywords:
cell;
immunotherapy;
tissue resident;
resident traits ... See more keywords